Naoto Azuma Kiyoshi Matsui Naoaki Hashimoto Takahiro Yoshikawa Hajime Sano
10.2169/internalmedicine.56.8168
Intern Med
2017;56(12):1585-1590.
anti-drug antibody biologics eosinophilia golimumab hypersensitivity reaction immunogenicity
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28626189/
Antibodies, Monoclonal / therapeutic use Antirheumatic Agents / therapeutic use Arthritis, Rheumatoid / drug therapy Eosinophilia / drug therapy
Antibodies, Monoclonal / therapeutic use Antirheumatic Agents / therapeutic use Arthritis, Rheumatoid / drug therapy Eosinophilia / drug therapy Case Reports Adalimumab / adverse effects Adult Antibodies, Monoclonal, Humanized / adverse effects Eosinophilia / etiology Female Humans Infliximab / adverse effects Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antirheumatic Agents golimumab Infliximab Adalimumab tocilizumab
PMC5505919
28626189
Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis
2017